Black Diamond Therapeutics, Inc. (BDTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 79
-0.02
-1.105%
$
106.58M Market Cap
- P/E Ratio
- Div Yield
708,200 Volume
-1.71 Eps
$ 1.81
Previous Close 
Want to track BDTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.98 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BDTX Earnings Reports FAQ
What is the earnings per share (EPS) for BDTX?
The current EPS is -1.71.
What is the company's earnings growth rate?
Black Diamond Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Black Diamond Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Black Diamond Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BDTX at this time, as Black Diamond Therapeutics, Inc has no recent EPS data to calculate it.
